SpyGlass Pharma SGP Income Statement (2024-2026)

NASDAQ SGP
$25.44 -0.54 (-2.08%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

SpyGlass Pharma Quarterly Income Statement

Periods 4 quarters
Latest Jun 2026

SpyGlass Pharma reported net income of -$19.86M for the quarter ended Jun 2026. This income statement covers 4 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

SpyGlass Pharma Income Statement API

Pull SpyGlass Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SGP&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY